ClinicalTrials.Veeva
Menu

Find clinical trials for Diabetes in Phoenix, AZ

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Diabetes Mellitus
Type 2 Diabetes Mellitus
Type 1 Diabetes Mellitus
Diabetic Foot
Foot Ulcer
Obesity
Ulcer

Diabetes trials near Phoenix, AZ, USA:

A Study of Oral Ladarixin in Recent Onset Type 1 Diabetes and a Low Residual β-cell Function

Objectives The objective of this clinical trial is to assess whether ladarixin treatment has an effect to preserve β-cell function and delay the prog...

Active, not recruiting
Recent Onset type1 Diabetes
Drug: Placebo
Drug: Ladarixin

Phase 2

Dompé
Dompé

Phoenix, Arizona, United States and 56 other locations

Hepatic and Cardiovascular endpoints for patients with Type 2 Diabetes who are inadequately controlled on one or more glucose lowering agent...

Enrolling
Type 2 Diabetes
Device: Duodenal Mucosal Resurfacing (Sham)
Device: Duodenal Mucosal Resurfacing (DMR)
Fractyl Health

Phoenix, Arizona, United States and 64 other locations

The main purpose of this study is to learn more about the safety and efficacy of investigational tirzepatide doses in participants with Type 2 diabetes...

Enrolling
Type 2 Diabetes
Obesity
Drug: Tirzepatide
Drug: Placebo

Phase 2

Lilly
Lilly

Tempe, Arizona, United States and 42 other locations

double-blind, placebo-controlled study of HTD1801 in adult subjects with non-alcoholic steatohepatitis and liver fibrosis who have type 2 diabetes...

Active, not recruiting
Type 2 Diabetes
Nonalcoholic Steatohepatitis (NASH)
Drug: Placebo
Drug: HTD1801

Phase 2

HighTide Therapeutics

Peoria, Arizona, United States and 54 other locations

The purpose of this study is to investigate the efficacy and safety of retatrutide compared with placebo in participants with Type 2 Diabetes...

Enrolling
Type 2 Diabetes
Drug: Retatrutide
Drug: Placebo

Phase 3

Lilly
Lilly

Sun City West, Arizona, United States and 61 other locations

Evaluate the Safety, Tolerability, and Efficacy of OTX-TKI in Subjects with Moderately Severe to Severe Non-proliferative Diabetic Retinopat...

Active, not recruiting
Non-proliferative Diabetic Retinopathy
Drug: OTX-TKI
Drug: Sham

Phase 1

Ocular Therapeutix
Ocular Therapeutix

Phoenix, Arizona, United States and 9 other locations

the treatment with the COMS One device in subjects with refractory diabetic foot ulcers (DFUs). The prospective randomized, double-blinded, ...

Enrolling
Diabetic Foot Ulcer
Device: COMS One device
Device: Sham device
Piomic Medical

Mesa, Arizona, United States and 22 other locations

it takes the body to remove it in pediatric participants with Type 2 Diabetes Mellitus (T2DM). The study will last for approximately 100 day...

Enrolling
Type 2 Diabetes Mellitus
Drug: LY3209590

Phase 1

Lilly
Lilly

Scottsdale, Arizona, United States and 10 other locations

Study GR41675 is a Multicenter, Randomized Study in Participants with Diabetic Retinopathy (DR) Without Center-Involved Diabetic Ma...

Active, not recruiting
Diabetic Retinopathy
Drug: PDS Implant Pre-Filled with 100 mg/mL Ranibizumab
Drug: Intravitreal Ranibizumab 0.5 mg Injection

Phase 3

Roche
Roche

Phoenix, Arizona, United States and 60 other locations

This is a randomized, masked, active-controlled, parallel-group, multi-center study that will assess the efficacy of ILUVIEN as a baseline therapy in...

Active, not recruiting
Diabetic Macular Edema
Drug: Aflibercept
Drug: Iluvien 0.19 MG Drug Implant

Phase 4

Alimera Sciences

Phoenix, Arizona, United States and 39 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems